This includes a pension contribution of 12% of salary.His predecessor joined on a similar annual salary of £1.1m but has been Nawana joined Smith & Nephew in May 2018 after turning around the US diagnostics firm Alere and overseeing its sale to Abbott for $5.3bn in 2017. “The technologies themselves were often of the highest calibre. He will be paid an annual salary of £1.08m, as part of a pay package of up to £5.5m including bonuses, dependent on performance. Namal Nawana, CEO of Smith & Nephew, ... Nawana was on a base salary of $1.5m, with the chance to earn an estimated annual maximum of about $7m for hitting targets.
When Namal Nawana was wooed to take the top job at Smith & Nephew, he took a hard look at the venerable UK medical devices company and found both a puzzle and an opportunity. He has resisted pressure from the British company’s activist investor Elliott Advisors to break itself up.Roberto Quarta, Smith & Nephew’s chairman, said Nawana had “substantially transformed the business with a new strategy, purpose and culture, and renewed commitment to innovation, returning it to an improved growth trajectory”.The company was founded in 1856 by Thomas James Smith, who was later joined by his nephew.Legislation protects those needed in future pandemics who may be struggling now He will join the Company and be appointed to the Board as an Executive Director on 7 May 2018. W hen Namal Nawana was wooed to take the top job at Smith & Nephew, he took a hard look at the venerable UK medical devices company and found both a puzzle and an opportunity. Joined the Board and was appointed Chief Executive Officer in May 2018.
© 2020 Guardian News & Media Limited or its affiliated companies. Prior to Smith & Nephew Namal was Chief Executive Officer and a member of the Board of Medical Diagnostics Company Alere Inc, until its $8 billion acquisition by Abbott in 2017.
Medical devices group gets new lease of life under deal making veteran. The Role of the Chief Executive Officer . All rights reserved. Career and Experience. Smith & Nephew plc (LSE:SN, NYSE:SNN), the global medical technology business, today announces the appointment of Namal Nawana as Chief Executive Officer. Try full digital access and see why over 1 million readers subscribe to the FTFT print edition delivered Monday - Saturday along with ePaper accessPremium FT.com access for multiple users, with integrations & admin toolsPurchase a Trial subscription for 1,00 € for 4 weeks You will be billed 60,50 € per month after the trial endsPurchase a Digital subscription for 6,50 € per week You will be billed 37,50 € per month after the trial endsPurchase a Print subscription for 14,98 € per week You will be billed 64,92 € per month after the trial endsPurchase a Team or Enterprise subscription for per week So, my initial impression was, why is a company with such great … Namal Nawana to be replaced by Roland Diggelmann at medical equipment makerThe chief executive of Smith & Nephew will step down after only 18 months in the job following a row over his pay.The company, which makes artificial knee and hip joints as well as wound dressings, He will be succeeded by Roland Diggelmann, a former Roche Diagnostics executive, who has been on the Smith & Nephew board as a non-executive director since March 2018.Diggelmann will take the helm on 1 November; Nawana will stay with the company until the end of December to “provide advice and assistance”.It is understood that Nawana, who is based in Andover in Massachusetts, is leaving because his requests for higher pay, in line with the packages awarded by US medical device-makers, could not be met under UK corporate governance standards.
Smith & Nephew, which makes artificial hip and knee replacements, said Nawana will “pursue other opportunities outside of the UK” but will be on hand to offer advice until the end of the year. Namal is based in Andover, US.
When Namal Nawana was wooed to take the top job at Smith & Nephew, he took a hard look at the venerable UK medical devices company and found both a puzzle and an opportunity. He has resisted pressure from the British company’s activist investor Elliott Advisors to break itself up.Roberto Quarta, Smith & Nephew’s chairman, said Nawana had “substantially transformed the business with a new strategy, purpose and culture, and renewed commitment to innovation, returning it to an improved growth trajectory”.The company was founded in 1856 by Thomas James Smith, who was later joined by his nephew.Legislation protects those needed in future pandemics who may be struggling now He will join the Company and be appointed to the Board as an Executive Director on 7 May 2018. W hen Namal Nawana was wooed to take the top job at Smith & Nephew, he took a hard look at the venerable UK medical devices company and found both a puzzle and an opportunity. Joined the Board and was appointed Chief Executive Officer in May 2018.
© 2020 Guardian News & Media Limited or its affiliated companies. Prior to Smith & Nephew Namal was Chief Executive Officer and a member of the Board of Medical Diagnostics Company Alere Inc, until its $8 billion acquisition by Abbott in 2017.
Medical devices group gets new lease of life under deal making veteran. The Role of the Chief Executive Officer . All rights reserved. Career and Experience. Smith & Nephew plc (LSE:SN, NYSE:SNN), the global medical technology business, today announces the appointment of Namal Nawana as Chief Executive Officer. Try full digital access and see why over 1 million readers subscribe to the FTFT print edition delivered Monday - Saturday along with ePaper accessPremium FT.com access for multiple users, with integrations & admin toolsPurchase a Trial subscription for 1,00 € for 4 weeks You will be billed 60,50 € per month after the trial endsPurchase a Digital subscription for 6,50 € per week You will be billed 37,50 € per month after the trial endsPurchase a Print subscription for 14,98 € per week You will be billed 64,92 € per month after the trial endsPurchase a Team or Enterprise subscription for per week So, my initial impression was, why is a company with such great … Namal Nawana to be replaced by Roland Diggelmann at medical equipment makerThe chief executive of Smith & Nephew will step down after only 18 months in the job following a row over his pay.The company, which makes artificial knee and hip joints as well as wound dressings, He will be succeeded by Roland Diggelmann, a former Roche Diagnostics executive, who has been on the Smith & Nephew board as a non-executive director since March 2018.Diggelmann will take the helm on 1 November; Nawana will stay with the company until the end of December to “provide advice and assistance”.It is understood that Nawana, who is based in Andover in Massachusetts, is leaving because his requests for higher pay, in line with the packages awarded by US medical device-makers, could not be met under UK corporate governance standards.
Smith & Nephew, which makes artificial hip and knee replacements, said Nawana will “pursue other opportunities outside of the UK” but will be on hand to offer advice until the end of the year. Namal is based in Andover, US.